BP

399.7

-7.59%↓

BP

399.7

-7.59%↓

BP

399.7

-7.59%↓

BP

399.7

-7.59%↓

BP

399.7

-7.59%↓

Search

Smith & Nephew PLC

Fechado

1,077.5 0.47

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1068.5

Máximo

1091

Indicadores-chave

By Trading Economics

Rendimento

107M

Vendas

1.4B

P/E

Médio do Setor

30.139

27.4

EPS

0.376

Rendimento de Dividendos

2.7

Margem de lucro

7.57

Funcionários

17,349

EBITDA

260M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+16.16% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.70%

4.42%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

455M

9.5B

Abertura anterior

1077.03

Fecho anterior

1077.5

Smith & Nephew PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

3 de abr. de 2025, 23:04 UTC

Principais Notícias

JPMorgan Raises Risk of U.S., Global Recession to 60%

3 de abr. de 2025, 22:40 UTC

Grandes Movimentos do Mercado

Aldeyra Shares Fall on FDA Complete Response Letter for Dry Eye Disease Drug

3 de abr. de 2025, 22:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Quantum Corp. Gets Strategic Investment, Names New Financial Chief

3 de abr. de 2025, 18:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Capital One, Discover Merger Clears Regulatory Hurdle, Sources Tell The New York Times

3 de abr. de 2025, 23:43 UTC

Conversa de Mercado

Gold Steady, Supported by Potential Safe-Haven Demand -- Market Talk

3 de abr. de 2025, 23:41 UTC

Conversa de Mercado

Nikkei May Fall as U.S. Tariffs Raise Concerns About Global Growth -- Market Talk

3 de abr. de 2025, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 de abr. de 2025, 22:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Is TikTok Getting Banned? What to Expect as the Deadline Approaches. -- Barrons.com

3 de abr. de 2025, 21:43 UTC

Principais Notícias
Ganhos

The Day Trump's Tariffs Shook Wall Street and Corporate America -- 5th Update

3 de abr. de 2025, 20:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

3 de abr. de 2025, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

3 de abr. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

3 de abr. de 2025, 20:43 UTC

Conversa de Mercado

Plummeting Toronto Home Sales Reflect Trade, Political Uncertainty -- Market Talk

3 de abr. de 2025, 20:34 UTC

Principais Notícias

Trump's Tariffs Were Supposed to Boost the Dollar, But Here's Why the Opposite Happened -- Heard on the Street -- 2nd Update

3 de abr. de 2025, 20:23 UTC

Principais Notícias

Trump Tariffs Send Dow Industrials to 1600-Point Decline; Dollar Slumps -- WSJ

3 de abr. de 2025, 20:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Blackstone Life Sciences And Anthos Therapeutics Announce Novartis Has Completed The Acquisition Of Anthos Therapeutics In A Deal Valued At Up To $3.1B, With $925M Paid Upfront >BX

3 de abr. de 2025, 19:55 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

3 de abr. de 2025, 19:55 UTC

Conversa de Mercado

Dollar Weakens as Investors Seek Safety Elsewhere -- Market Talk

3 de abr. de 2025, 19:21 UTC

Conversa de Mercado

Oil Futures Slide on U.S. Tariffs, OPEC+ Output Plan -- Market Talk

3 de abr. de 2025, 19:15 UTC

Conversa de Mercado

U.S. Natural Gas Stays Focused on Weather, Storage -- Market Talk

3 de abr. de 2025, 18:45 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

3 de abr. de 2025, 18:45 UTC

Conversa de Mercado

Gold Drops In Tariff Fallout -- Market Talk

3 de abr. de 2025, 18:39 UTC

Conversa de Mercado

U.S. Tariffs Could Give Natural Gas Edge Over Solar -- Market Talk

3 de abr. de 2025, 18:38 UTC

Principais Notícias

Trump Tariffs Send Dow Industrials to 1400-Point Decline; Dollar Slumps -- WSJ

3 de abr. de 2025, 18:30 UTC

Principais Notícias

Auto Industry Braces for Major Pain From Trump's Tariffs -- Analysis

3 de abr. de 2025, 18:20 UTC

Conversa de Mercado

Uncertainty Still Roils Companies in Tariff Saga -- Market Talk

3 de abr. de 2025, 18:18 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

3 de abr. de 2025, 18:17 UTC

Conversa de Mercado

U.S. Workers Can't Match International Labor as Companies Consider Moving Supply Chains -- Market Talk

3 de abr. de 2025, 18:04 UTC

Conversa de Mercado

US Sees More Job Openings in Construction, Transportation -- Market Talk

3 de abr. de 2025, 17:55 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparação entre Pares

Variação de preço

Smith & Nephew PLC Previsão

Preço-alvo

By TipRanks

16.16% parte superior

Previsão para 12 meses

Média 1,248.7 GBX  16.16%

Máximo 1,400 GBX

Mínimo 1,025 GBX

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Smith & Nephew PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

5

Comprar

5

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

EBITDA

Resultado Operacional

$

Sobre Smith & Nephew PLC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.